Supplementary
. Oxaliplatin resistance in mPGES-1-negative RKO cell lines is independent of PGE 2 /EP4 signaling (i) RKO cells were treated with varying concentrations of oxaliplatin for 72 hours and cell viability was determined by the MTT assay. Data represent the means +/-SEM of two independent experiments performed in duplicate. The dose-response curves and IC50 values were determined by a non-linear regression fit. ***P<0.0001 compared with RKO PAR cells (extra sum-of-squares F-test). (ii) RT-PCR analyses for mPGES-1 mRNA prepared from untreated OXR and PAR cells. Columns represent the means +/-SEM of quadruplicate samples. (iii) Western blot analyses for COX-2 and mPGES-1 protein prepared from untreated HT29 OXR, HT29 PAR, RKO OXR and RKO PAR cells. (iv) RKO OXR or PAR cells were treated with increasing concentrations of either oxaliplatin alone (control), or cotreated with 1 µM L-161,982 for 72h. Cell viability was assessed using the MTT assay. Data represent the means +/-SEM of two independent experiments performed in duplicate. Doseresponse curves and IC50 values were determined by nonlinear regression fit followed by the extra sum-of-squares F-test. 
